What Does an Elevated LDH Level Mean in Cancer?

LDH is a routine blood test, and when it comes back high in someone with cancer, it usually points to more active disease rather than to any one specific problem. Across many cancers, from melanoma to lymphoma to stomach and lung cancer, a high LDH before treatment goes along with a harder road ahead.1PubMed Central. Prognostic value of lactate dehydrogenase for melanoma patients receiving anti-PD-1/PD-L1 therapy2PubMed Central. LDH and glycolytic activity as predictors of immunotherapy response in gastric cancer: a systematic review and meta-analysis3Journal of Clinical Oncology. Serum lactate dehydrogenase (LDH) as a biomarker for survival with mTOR inhibition in patients with metastatic renal cell carcinoma (RCC). It is a broad signal, not a verdict. Plenty of things besides cancer raise it, and a single reading says less than the trend over weeks of treatment.

What LDH Is and Why Cancer Raises It

LDH, short for lactate dehydrogenase, is an enzyme that helps cells turn sugar into energy by converting pyruvate into lactate.4PubMed Central. Excess exogenous pyruvate inhibits lactate dehydrogenase activity in live cells in an MCT1-dependent manner5PubMed Central. Energy Landscape of the Michaelis Complex of Lactate Denaturing: Relationship to Catalytic Mechanism It sits inside almost every tissue in the body, so damage to cells anywhere can release it into the blood. A blood LDH level therefore shows how much cell turnover or damage is happening somewhere, without saying where. Your report usually prints LDH next to a normal range, and results are often described against the top of that range, the upper limit of normal (ULN).

A result flagged “H” means only that it is above that lab’s reference interval. A mildly high number and a very high number carry different weight, so the size of the gap above the top of the normal range matters more than the flag itself. Normal ranges also differ between labs, so compare your number with the range printed on your own report.

Many cancer cells burn sugar quickly into lactate even when oxygen is available, and LDH is central to this.6bioRxiv. AI-Guided Discovery of LDHA Inhibitors Targeting Cancer Metabolism Using Machine Learning and Generative Chemistry: An End-to-End Drug Discovery Pipeline The gene for one form of LDH is switched on more strongly in most tumor types than in normal tissue.7PubMed Central. Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells The oxygen-starved centers of growing tumors also trigger a stress signal that turns up LDH production.8PubMed Central. HIF1/2α mediates hypoxia-induced LDHA expression in human pancreatic cancer cells9British Journal of Cancer. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis So bigger, faster-growing tumors with poor blood supply tend to make and release more LDH.10PubMed Central. Lactate dehydrogenase is not a useful marker for relapse in patients on surveillance for stage I germ cell tumours11Journal of Clinical Oncology. Serum lactate dehydrogenase (LDH) as a biomarker for survival with mTOR inhibition in patients with metastatic renal cell carcinoma (RCC).

Getting from tumor to blood test is mostly a matter of leakage. Tumor cells that divide quickly and die quickly spill their contents, LDH included, into the bloodstream, and dead tissue in the middle of a large tumor does the same.

It also is not a tumor ruler. LDH reflects activity as much as size, so a small but fast-growing cancer can raise it more than a large slow one. Tumor type matters too: lymphomas, germ cell tumors and melanoma raise it more often than many others, and spread to the liver can add to it because liver tissue is rich in the enzyme and is being damaged. Two people with the same stage of different cancers can have very different levels, and neither is necessarily doing better.

A normal LDH does not rule out cancer or active disease, because many tumors never raise it. That is why it is used to add information about someone already diagnosed, not to screen healthy people.

What a High LDH Says About Outlook

The link to outlook shows up in many cancers. In melanoma treated with immunotherapy drugs, a high LDH before treatment went with roughly 2.4 times the risk of death compared with normal LDH.12PubMed Central. Prognostic value of lactate dehydrogenase for melanoma patients receiving anti-PD-1/PD-L1 therapy In stage IV melanoma, it was one of the strongest independent predictors of survival.13PubMed Central. Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma In stomach cancer treated with immunotherapy, LDH above the normal range roughly doubled the risk of death, a finding consistent across 16 studies.14PubMed Central. LDH and glycolytic activity as predictors of immunotherapy response in gastric cancer: a systematic review and meta-analysis In advanced kidney cancer, it also roughly doubled the risk,15Journal of Clinical Oncology. Serum lactate dehydrogenase (LDH) as a biomarker for survival with mTOR inhibition in patients with metastatic renal cell carcinoma (RCC). and in Ewing’s sarcoma, a bone cancer, high LDH roughly tripled it.16PubMed Central. Prognostic significance of serum lactate dehydrogenase levels in Ewing’s sarcoma: A meta-analysis

A high level reflects a heavy or fast-growing tumor burden, which tends to be harder to treat. It tends to matter most in advanced cancer.

In some cancers LDH is built into official staging. In advanced testicular (germ cell) cancer, the LDH level is part of the risk grouping doctors use to plan treatment.17PubMed Central. Lactate dehydrogenase is not a useful marker for relapse in patients on surveillance for stage I germ cell tumours It is high in about 60% of men with advanced nonseminoma and about 80% with advanced seminoma.18PubMed Central. Lactate dehydrogenase is not a useful marker for relapse in patients on surveillance for stage I germ cell tumours In diffuse large B-cell lymphoma, LDH is part of the standard risk score, and comparing it with immune cell counts can sharpen the picture further.19PubMed Central. A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival In these cancers, your LDH result may directly affect which treatment group you are placed in.

Where LDH is part of a score, it is combined with factors such as stage, age and number of affected sites. Where it is not part of official staging, a high LDH is still noted but does not formally change your group.

High LDH generally means more cancer in the body, but about a quarter of people with high LDH in one large melanoma study had below-average tumor size.20PubMed Central. Lactate dehydrogenase: a marker of diminished antitumor immunity So LDH carries information beyond how much tumor there is.21PubMed Central. Lactate dehydrogenase: a marker of diminished antitumor immunity

The figures above compare large groups, not individuals. Doubled risk does not mean half as long to live; it means events happened more often in the high group. Many people with high LDH still respond well to treatment, and your doctor weighs LDH with stage, scans, fitness and tumor type.

Useful questions to bring to your oncologist: Is LDH part of the official staging for my cancer type? How far above normal is my level? Has it been checked more than once? Does it change the treatment you recommend?

Why High LDH Can Weaken the Immune Attack on Cancer

Tumors with high LDH pour out lactic acid around themselves.22PubMed. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells That lactic acid switches off T cells and natural killer cells, the immune cells that kill cancer cells,23PubMed. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells24PubMed. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells and it boosts immune cells that hold the immune response back.25PubMed. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells High LDH may therefore mark a tumor that is better at hiding from the immune system, the system immunotherapy drugs rely on. Studies show high LDH goes with poorer results, which does not by itself prove lactate is the reason: a large tumor burden could explain both the high LDH and the poorer outcome.

LDH predicts outlook but not which drug is better. In advanced lung cancer, people with high LDH did worse whether they got immunotherapy or chemotherapy, and LDH level did not show that either treatment was the better choice.26PubMed Central. Pre‐ and on‐treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non–small cell lung cancer A high LDH is not, by itself, a reason to skip or switch to immunotherapy. The studies show lower average results, not no benefit, and treatment choice depends on the cancer type and other markers your oncologist checks.

Because tumors lean on LDH, scientists are designing drugs to block it. This is still early laboratory work, and no such drug is available as a treatment. If it interests you, ask about clinical trials.

What Changes in LDH During Treatment Mean

In metastatic breast cancer, LDH that stayed high after 12 weeks of first treatment went with nearly three times the risk of the cancer progressing.27PubMed Central. Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker LDH that rose from normal to high over those 12 weeks went with about four times the risk.28PubMed Central. Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker LDH can also help track recurrence and response in breast cancer.29Biomedical and Pharmacology Journal. Lactate Dehydrogenase and Biochemical Markers as Indicators of Treatment Response in Breast Cancer

If LDH was high at the start and drops toward the normal range as treatment proceeds, that often fits the tumor shrinking and fewer cells breaking down. It is encouraging but does not replace scans, which show directly what is happening to the tumor. A drop can also come from other causes, such as resolving liver irritation.

An LDH that stays high after several months of treatment can mean the cancer is not responding as hoped, but it is one clue among several. A rise from a normal level is often considered more concerning than a level that was always mildly high, though other causes still need to be ruled out. Doctors usually respond by ordering scans or other tests, not by changing treatment on LDH alone.

It is not reliable for every cancer or stage. In early stage I testicular cancer being watched after surgery, LDH was not a useful sign of the cancer coming back.30PubMed Central. Lactate dehydrogenase is not a useful marker for relapse in patients on surveillance for stage I germ cell tumours Whether it is worth tracking depends on your cancer type and stage, which your doctor can tell you.

To follow your own trend, keep copies of each result with dates, and compare against the same lab when possible, since normal ranges differ. Look at direction over several tests rather than one bump, and bring the series to appointments to ask how it fits your scans.

A steady climb over weeks is worth raising at your next visit. A sudden very high reading with new symptoms needs prompt contact with your team. One small rise alone is often rechecked before any decision.

When a Spike in LDH Means Tumors Are Breaking Down

A very high LDH is a sign of rapid cell turnover and goes with more aggressive cancers.31OncLive. Overview on Tumor Lysis Syndrome: Incidence and Risk Factors Doctors use it to judge who is at risk of tumor lysis syndrome, where dying cancer cells release so much content that it strains the kidneys and heart.32OncLive. Overview on Tumor Lysis Syndrome: Incidence and Risk Factors In one reported case of myeloma, LDH shot up dramatically as treatment destroyed the cancer quickly.33Blood. Extremely Elevated Lactate Dehydrogenase and Aspartate Aminotransferase Level as an Indicator of Tumor Lysis during Bortezomib Treatment in a Multiple Myeloma Patient: Case Report

A sharp rise just after starting treatment does not always mean the cancer is growing: in a fast-growing cancer, a jump in LDH a few days after first treatment can mean cells are dying quickly. Doctors tell this apart from cancer growth by the timing, the other blood chemistry results and how the person feels. Later scans and a continued fall in LDH help confirm the rise was a passing effect.

When many cells die at once, they release potassium, phosphate and uric acid into the blood faster than the kidneys can clear them. High potassium can disturb the heartbeat, and the build-up of uric acid and phosphate can injure the kidneys. So LDH is only one part of early-treatment blood work, alongside kidney function and these minerals.

Tumor lysis is most common with blood cancers like leukemia and lymphoma. Doctors check blood several times early in treatment and may give fluids or medicines to protect the kidneys. Little urine, cramps, nausea or an irregular heartbeat need urgent care. Ask your team before treatment starts whether you are at risk.

Other Causes of a High LDH

Many illnesses raise LDH:

Damage to any of these tissues releases LDH, so the number alone cannot say which tissue is involved.

In people with cancer there are added reasons. Chemotherapy and some other cancer drugs can injure the liver or other organs and raise LDH even when the tumor is shrinking. Infections during treatment, when immune defenses are low, can add to it. A rise during treatment does not automatically point to the cancer, and your team will look for these other explanations first.

The sample itself can also give a falsely high reading. Red blood cells are packed with LDH, so if they burst in the tube, the result reads falsely high.40Needle.Tube. The Impact of Hemolysis on LDH and AST Levels in Blood Tests: Importance for Healthcare Professionals Sending samples through a hospital’s pneumatic tube system raised LDH by about a quarter to one and a half times, even without burst red cells.41PubMed. Falsely Increased Plasma Lactate Dehydrogenase without Hemolysis Following Transport through Pneumatic Tube System A surprising high result with no other change is often simply repeated.

To sort out the cause, doctors compare LDH with other tests such as liver enzymes, troponin for the heart, or a blood count. Hard exercise or a recent injury can matter, so mention them. If a carefully handled repeat comes back normal, the first number was probably a sample problem. If it stays high, the next step is usually to look for the source with other blood tests, imaging or a review of medicines. A repeat is routine and not a sign that your team suspects something worse.

Preparing for Your Next LDH Test

Since muscle injury and liver strain raise LDH, avoid unusually hard workouts in the day or two before a draw. Tell your team about new medicines, alcohol, or recent infections. Having tests at the same lab keeps the normal range consistent.

Mention recent falls or injections into muscle. Bring a list of all medicines and supplements, since some can affect the liver and so the result. At the appointment, bring any symptoms like new pain, fatigue or dark urine, and ask when the next recheck is planned.